Reduction in animal numbers required for antisera production using the subcutaneous chamber technique in rabbits.
The purpose of this study was to determine if the subcutaneous chamber technique would reduce the number of rabbits required for antisera production by enabling serial use of individual animals for multiple antigens. Rabbits were assigned to immunization protocols against two antigens in series that involved combinations of chamber implantation, Freund's adjuvant and injection of antigen either by the subcutaneous route or by direct inoculation into the chamber. Results indicate the systemic immune response to both antigens achieved similar magnitude and duration by use of either Freund's adjuvant or direct inoculation of antigen into the chamber, suggesting that chamber use may be able to replace use of Complete Freund's adjuvant for many antigens. Rabbits re-used for a second antigen were equally successful in production of significant titres in both serum and chamber fluid without evidence of either a significant inflammatory response due to the chronic presence of the implant or a decrease in the yield of antisera harvested from the chamber. These results support the advantages of chamber use as reported by others and demonstrate that the chamber technique can significantly extend the productive life of an individual animal that would otherwise be euthanized following a single use in antisera production.
Whary
M T
MT
Laboratory Animal Resources, Pennsylvania State University, University Park 16802, USA.
Carey
D D
DD
Ferguson
F G
FG
D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000818:Animals; D000830:Animals, Laboratory; D000941:Antigens / Q000276:immunology; D002772:Cholera Toxin / Q000276:immunology*; D015194:Diffusion Chambers, Culture; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D005620:Freund's Adjuvant; D006241:Haptens / Q000276:immunology; D006433:Hemocyanins / Q000008:administration & dosage / Q000276:immunology*; D007106:Immune Sera / Q000096:biosynthesis*; D007279:Injections, Subcutaneous / Q000662:veterinary; D008297:Male; D008974:Mollusca / Q000276:immunology; D011817:Rabbits / Q000276:immunology*; D011897:Random Allocation; D013047:Specific Pathogen-Free Organisms; D013997:Time Factors
D000276:Adjuvants, Immunologic; D000941:Antigens; D006241:Haptens; D007106:Immune Sera; D005620:Freund's Adjuvant; D002772:Cholera Toxin; D006433:Hemocyanins; C032808:keyhole-limpet hemocyanin